Listed company MEI Pharma completes $100 million private placement, to be used for Litecoin strategic reserves

Odaily News MEI Pharma announced the completion of a $100 million private placement financing, selling 29,239,767 shares of common stock or prepaid warrants of equivalent value at $3.42 per share. The proceeds will be used to establish a strategic reserve of Litecoin.
The company also appointed Charlie Lee, the founder of Litecoin and the lead investor in this private placement, to join the board of directors, and designated GSR as its digital asset and fund management consultant to oversee the execution of Litecoin reserve strategy. (Businesswire)